Vascular calcification and hypertension: Cause and effect

Annals of Medicine

Volumn 44, Issue SUPPL. 1, 2012, Pages

  Kalra, Sundeep S ^a,b   Shanahan, Catherine M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; calcification; coronary artery disease; hypertension; vascular smooth muscle cells

Indexed keywords

ARTERIAL STIFFNESS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SYSTOLIC HYPERTENSION;

CALCINOSIS; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; TUNICA INTIMA; TUNICA MEDIA; VASCULAR DISEASES;

EID: 84862558202     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2012.660498     Document Type: Review

References (86)

1. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc. 1976;35:156-62.
2. Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI - Atheromatous affection of arteries. 1858. Nutr Rev. 1989;47:23-5.
3. Murphy WAJr, NeddenDz D, Gostner P, Knapp R, Recheis W, Seidler H. The iceman: discovery and imaging. Radiology. 2003;226:614-29.
4. Pollack OJ. Experimental arteriopathies in the rabbit. In: Roberts JC and Straus R. Harper, editors. Comparative atherosclerosis: the morphology of spontaneous and induced atherosclerotic lesions in animals and its relation to human disease. New York, USA: Harper and Row; 1965, p. 291-308.
5. McCarthy JH, Palmer FJ. Incidence and significance of coronary artery calcification. Br Heart J. 1974;36:499-506.
6. Haust MD, More RH. Spontaneous lesions of the aorta in the rabbit. In: Comparative atherosclerosis: the morphology of spontaneous and induced atherosclerotic lesions in animals and its relation to human disease. 1965. p. 255-75.
7. Proudfoot D, Shanahan CM, Weissberg PL. Vascular calcification: new insights into an old problem. J Pathol. 1998;185:1-3.
8. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007;20:103-9.
9. Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: Intima versus media. Herz. 2001;26:245-51. (Pubitemid 32612692)
10. Stary H. Atlas of atherosclerosis: progression and regression. New York, USA: Parthenon; 1999.
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-9. (Pubitemid 23132154)
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-32. (Pubitemid 20101575)
13. Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. J Am CollCardiol. 1994; 74:1272-4. (Pubitemid 24375022)
14. Honye J, Mahon DJ, Jain A, White CJ, Ramee SR, Wallis JB, et al. Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation. 1992;85:1012-25.
15. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 2000;36:326-40. (Pubitemid 30466157)
16. Simon A, Levenson J. Early detection of subclinical atherosclerosis in asymptomatic subjects at high risk for cardiovascular disease. Clin Exp Hypertens. 1993;15:1069-76. (Pubitemid 23344581)
17. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation. 1996;94:1175-92. (Pubitemid 26292883)
18. Gross M-L, Meyer H-P, Ziebart H, Rieger P, Wenzel U, Amann K, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007;2:121-34.
19. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol. 2009;4:1892-900.
20. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:218-23. (Pubitemid 30064276)
21. Sharma SK, Israel DH, Kamean JL, Bodian CA, Ambrose JA. Clinical, angiographic, and procedural determinants of major and minor coronary dissection during angioplasty. Am Heart J. 1993;126:39-47. (Pubitemid 23201572)
22. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-63. (Pubitemid 26099346)
23. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation. 2001;103:1051-6. (Pubitemid 32200176)
24. Doherty TM, Detrano RC. Coronary arterial calcification as an active process: A new perspective on an old problem. Calcif Tissue Int. 1994;54:224-30. (Pubitemid 24076579)
25. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 1989;2:941-4. (Pubitemid 19255745)
26. Ge J, Chirillo F, Schwedtmann J, Görge G, Haude M, Baumgart D, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart. 1999;81:621-7. (Pubitemid 29260188)
27. Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110:3424-9. (Pubitemid 39602220)
28. Li X, Kramer MC, van der Loos CM, Koch KT, de Boer OJ, Henriques JPS, et al. A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction. Atherosclerosis. 2011;218:83-9.
29. Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol. 2003;16:267-72. (Pubitemid 36667908)
30. Vengrenyuk Y, Carlier S, Xanthos S, Cardoso L, Ganatos P, Virmani R, et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. ProcNatlAcadSci USA. 2006;103:14678-83. (Pubitemid 44527789)
31. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res. 2008;103:e28-34.
32. Proudfoot D, Shanahan CM. Nanocrystals seed calcification in more ways than one. Kidney Int. 2011;79:379-82.
33. Shanahan CM. Inflammation ushers in calcification: a cycle of damage and protection? Circulation. 2007;116:2782-5. (Pubitemid 350291219)
34. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.Eur Heart J. 2007;28:2375-414.
35. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J. Calcification of medial elastic fibers and aortic elasticity. Hypertension. 1997;29:999-1006. (Pubitemid 27152472)
36. Essalihi R, Dao HH, Yamaguchi N, Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens. 2003;16:103-10. (Pubitemid 36143427)
37. Guérin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15:1014-21. (Pubitemid 30410374)
38. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938-42. (Pubitemid 34258697)
39. London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol. 2003;14(Suppl 4):S305-9. (Pubitemid 37052395)
40. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant. 2008;23:586-93. (Pubitemid 351767633)
41. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res. 2005;66:307-17. (Pubitemid 40471045)
42. Henrion D, Chillon JM, Godeau G, Muller F, Capdeville-Atkinson C, Hoffman M, et al. The consequences of aortic calcium overload following vitamin D3 plus nicotine treatment in young rats. J Hypertens. 1991;9:919-26.
43. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension. 2009;53:524-31.
44. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-605. (Pubitemid 44627304)
45. Golestani R, Tio R, Zeebregts CJ, Zeilstra A, Dierckx RA, Boersma HH, et al. Abdominal aortic calcification detected by dual X-ray absorptiometry: A strong predictor for cardiovascular events. Ann Med. 2010;42:539-45.
46. Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski J-M, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am SocNephrol. 2011;6:153-9.
47. vanPopele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001;32:454-60. (Pubitemid 32155234)
48. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Bio. 1998;18:379-88. (Pubitemid 28125632)
49. Schmid K, McSharry WO, Pameijer CH, Binette JP. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis. 1980;37:199-210. (Pubitemid 10005712)
50. Carlstrom D, Engfeldt B, Engstrom A, Ringertz N. Studies on the chemical composition of normal and abnormal blood vessel walls. I. Chemical nature of vascular calcified deposits. Lab Invest. 1953;2:325-35.
51. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop Relat Res. 1995;(314):266-80.
52. Kirsch T, Nah HD, Shapiro IM, Pacifici M. Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol. 1997;137:1149-60. (Pubitemid 27251049)
53. Anderson HC. Calcific diseases. A concept. Arch Pathol Lab Med. 1983;107:341-8. (Pubitemid 13053644)
54. Feldman T, Glagov S, Carroll JD. Restenosis following successful balloon valvuloplasty: bone formation in aortic valve leaflets. Cathet Cardiovasc Diagn. 1993;29:1-7. (Pubitemid 23145557)
55. Bunting CH. The formation of true bone with cellular (red) marrow in a sclerotic aorta. J Exp Med. 1906;8:365-76.
56. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522-8. (Pubitemid 32226259)
57. Hunt JL, Fairman R, Mitchell ME, Carpenter JP, Golden M, Khalapyan T, et al. Bone formation in carotid plaques: a clinicopathological study. Stroke. 2002;33:1214-9. (Pubitemid 34517038)
58. Tanimura A, McGregor DH, Anderson HC. Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med. 1983;172:173-7. (Pubitemid 13143185)
59. Kockx MM, Muhring J, Bortier H, De Meyer GR, Jacob W. Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 1996;148:1771-7. (Pubitemid 26170508)
60. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA. 1998;95:3094-9. (Pubitemid 28135860)
61. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81. (Pubitemid 27130923)
62. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21:142-4. (Pubitemid 29036302)
63. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998;18:333-8. (Pubitemid 28125626)
64. Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Ex MolPathol. 1985;42:139-62. (Pubitemid 15096803)
65. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med. 2006;260:192-210. (Pubitemid 44253633)
66. Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91: 1800-9. (Pubitemid 23127387)
67. Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93:2106-13.
68. Mayr M, Grainger D, Mayr U, Leroyer AS, Leseche G, Sidibe A, et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardio vasc Genet. 2009;2:379-88.
69. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15:2857-67. (Pubitemid 41103395)
70. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87:1055-62.
71. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-402. (Pubitemid 24177151)
72. Westenfeld R, Jahnen-Dechent W, Ketteler M. Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med. 2007;17:124-8. (Pubitemid 46670022)
73. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697-11.
74. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res. 2011;109:e1-12.
75. Chen NX, Kircelli F, O'Neill KD, Chen X, Moe SM. Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int. 2010;77:436-42.
76. Budoff MJ, Lane KL, Bakhsheshi H, Mao S, Grassmann BO, Friedman BC, et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol. 2000;86:8-11. (Pubitemid 30365135)
77. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation. 2002;106:1077-82. (Pubitemid 34970847)
78. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998;339:1972-8. (Pubitemid 29024129)
79. McCullough PA, Chinnaiyan KM. Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med. 2009;169:2064-70.
80. Essalihi R, Zandvliet ML, Moreau S, Gilbert L-A, Bouvet C, Lenoël C, et al. Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension. J Hypertens. 2007;25:1879-86. (Pubitemid 47356628)
81. Armstrong ZB, Boughner DR, Drangova M, Rogers KA. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovasc Res. 2011;90:165-70.
82. Dao HH, Essalihi R, Graillon J-F, Larivière R, De Champlain J, Moreau P. Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J Hypertens. 2002;20:1597-606. (Pubitemid 34921184)
83. Fleckenstein-Grün G, Thimm F, Frey M, Czirfusz A. Role of calcium in arteriosclerosis-experimental evaluation of antiarteriosclerotic potencies of Ca antagonists. Study Group for Calcium Antagonism. Basic Res Cardiol. 1994;89(Suppl 1):145-59. (Pubitemid 24314606)
84. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004;110:3480-7. (Pubitemid 39602227)
85. Qin X, Corriere MA, Matrisian LM, Guzman RJ. Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol. 2006;26:1510-6. (Pubitemid 44288976)
86. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Pusalkar P, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler-Thromb Vasc Biol. 2005;25:372.